Pharmacokinetics in Adolescents - PEAK

Study identifier:D9830C00021

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An open, single centre, phase I study in male adolescents with asthma, aged 12 to 17 years, to assess pharmacokinetics of orally administered AZD1981 tablets 100 mg twice daily for 61/2 days

Medical condition

asthma

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD1981 100 mg twice daily for 61/2 days

Sex

Male

Actual Enrollment

21

Study type

Interventional

Age

12 Years - 17 Years

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Feb 2011
Study Completion Date: 01 Feb 2011

Study design

Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria